These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 18280952
1. Giant mature ovarian cystic teratoma including more than 300 teeth. Devoize L, Collangettes D, Le Bouëdec G, Mishellany F, Orliaguet T, Dallel R, Baudet-Pommel M. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):e76-9. PubMed ID: 18280952 [Abstract] [Full Text] [Related]
2. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary. Suzuki M, Tamura N, Kobayashi H, Ohwada M, Terao T, Sato I. Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350 [Abstract] [Full Text] [Related]
4. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma. Kataoka T, Watanabe Y, Hoshiai H. J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880 [Abstract] [Full Text] [Related]
5. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary. Kikkawa F, Nawa A, Tamakoshi K, Ishikawa H, Kuzuya K, Suganuma N, Hattori S, Furui K, Kawai M, Arii Y. Cancer; 1998 Jun 01; 82(11):2249-55. PubMed ID: 9610706 [Abstract] [Full Text] [Related]
6. Clinical usefulness of serum squamous cell carcinoma antigen for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary. Miyazaki K, Tokunaga T, Katabuchi H, Ohba T, Tashiro H, Okamura H. Obstet Gynecol; 1991 Sep 01; 78(3 Pt 2):562-6. PubMed ID: 1870825 [Abstract] [Full Text] [Related]
7. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors]. Konishi I, Fujii S, Okamura H, Sakahara H, Endo K, Torizuka K, Suzuki A, Mori T. Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun 01; 38(6):827-36. PubMed ID: 2426374 [Abstract] [Full Text] [Related]
13. Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution. Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH. Eur J Obstet Gynecol Reprod Biol; 2008 Dec 01; 141(2):173-8. PubMed ID: 18823690 [Abstract] [Full Text] [Related]
15. [Significance of tumor markers in the treatment of patients with ovarian malignancies]. Tomoda Y, Kano T, Furuhashi Y, Mizuno K, Kamiya N, Mizuno K, Sakakibara K, Ohta M. Gan To Kagaku Ryoho; 1987 Nov 01; 14(11):3027-33. PubMed ID: 2445293 [Abstract] [Full Text] [Related]
16. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Ando S, Kimura H, Iwai N, Shima M, Ando M, Kuriyama T. Anticancer Res; 2001 Nov 01; 21(4B):3085-92. PubMed ID: 11712815 [Abstract] [Full Text] [Related]
18. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma. Pulay T, Csömör S, Mészáros K, Szarka G, Csabay L, Szinnyai A. Neoplasma; 1987 Nov 01; 34(5):595-600. PubMed ID: 2447510 [Abstract] [Full Text] [Related]
19. Intestinal metastases in a squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case report. Brustmann H. Ann Diagn Pathol; 2006 Dec 01; 10(6):374-5. PubMed ID: 17126259 [Abstract] [Full Text] [Related]